Dec 16, 2014

Mosquito-borne dengue targeted by antibody with hope for vaccine

Scientists have discovered new antibodies that neutralize viruses that cause dengue, potentially putting a universal vaccine within reach for a mosquito-borne illness that strikes an estimated 400 million people a year. The antibodies are effective against all four dengue viruses, according to an article ...

Nov 27, 2014

Ebola vaccine from Glaxo passes early safety test

An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine. The trial, which ...

Oct 27, 2014

Fujifilm to buy U.S. vaccine maker to expand biopharmaceutical business

Fujifilm Corp. said Monday it will acquire U.S. vaccine maker Kalon Biotherapeutics LLC to expand its biopharmaceutical business, with the Tokyo-based firm already having gained prominence for offering a possible treatment for Ebola patients. A Fujifilm subsidiary in the United States last Wednesday signed ...

Oct 23, 2014

J&J to start testing Ebola vaccine in January

U.S. healthcare giant Johnson & Johnson said Wednesday it would spend up to $200 million to speed up and expand its Ebola vaccine program, with testing slated to begin in January. Johnson & Johnson said its unit Janssen Pharmaceutical Companies was closely working with ...

Dec 12, 2013

Japan panel misled over cervical cancer vaccine decision

An article about the cervical cancer vaccine Cervarix that was used by a health ministry panel to justify subsidies for the drug was written by an employee of its manufacturer, GlaxoSmithKline K.K., informed sources said. According to the Japanese unit of Britain’s GlaxoSmithKline PLC, ...

Jun 25, 2013

Women get priority as rubella vaccine shortage looms

Amid its multiyear battle to halt the rubella epidemic, the health ministry has given priority to women in light of a feared vaccine shortage that could strike as early as August. The ministry, which had been encouraging a wider swath of the public to ...

May 31, 2013

New vaccine can cut malaria risk by 70%

A team of researchers led by a Japanese professor has developed a vaccine that cuts the risk of malaria in humans by some 70 percent, according to a recent article published in the U.S. journal PLOS One. If the vaccine is put to practical ...